842 related articles for article (PubMed ID: 33688802)
1. Implication of efflux pumps and
Abbes S; Sellami H; Neji S; Trabelsi H; Makni F; Ayadi A
J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33688802
[No Abstract] [Full Text] [Related]
2.
Nobrega de Almeida J; Jimenez-Ortigosa C; Francisco EC; Colombo AL; Perlin DS
Antimicrob Agents Chemother; 2022 Dec; 66(12):e0110122. PubMed ID: 36374073
[TBL] [Abstract][Full Text] [Related]
3. Species distribution and antifungal susceptibility of 358 Trichosporon clinical isolates collected in 24 medical centres.
Francisco EC; de Almeida Junior JN; de Queiroz Telles F; Aquino VR; Mendes AVA; de Andrade Barberino MGM; de Tarso O Castro P; Guimarães T; Hahn RC; Padovan ACB; Chaves GM; Colombo AL
Clin Microbiol Infect; 2019 Jul; 25(7):909.e1-909.e5. PubMed ID: 30991116
[TBL] [Abstract][Full Text] [Related]
4. Genomic and transcriptome identification of fluconazole-resistant genes for Trichosporon asahii.
Xia Z; Yu H; Wang C; Ding X; Zhang D; Tan X; Chen J; Hu S; Yang R
Med Mycol; 2020 Apr; 58(3):393-400. PubMed ID: 31504756
[TBL] [Abstract][Full Text] [Related]
5. Susceptibilities to amphotericin B, fluconazole and voriconazole of Trichosporon clinical isolates.
Tsai MS; Yang YL; Wang AH; Wang LS; Lu DC; Liou CH; Hsieh LY; Wu CJ; Cheng MF; Shi ZY; Lo HJ
Mycopathologia; 2012 Aug; 174(2):121-30. PubMed ID: 22318636
[TBL] [Abstract][Full Text] [Related]
6. Mutations and/or Overexpressions of ERG4 and ERG11 Genes in Clinical Azoles-Resistant Isolates of Candida albicans.
Feng W; Yang J; Xi Z; Qiao Z; Lv Y; Wang Y; Ma Y; Wang Y; Cen W
Microb Drug Resist; 2017 Jul; 23(5):563-570. PubMed ID: 27976986
[TBL] [Abstract][Full Text] [Related]
7. The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin.
Mariné M; Bom VL; de Castro PA; Winkelstroter LK; Ramalho LN; Brown NA; Goldman GH
Virulence; 2015; 6(5):476-86. PubMed ID: 25751127
[TBL] [Abstract][Full Text] [Related]
8. Antifungal Effects of Voriconazole-Loaded Nano-Liposome on Fluconazole
Hassanpour P; Hamishehkar H; Bahari Baroughi B; Baradaran B; Sandoghchian Shotorbani S; Mohammadi M; Shomali N; Aghebati-Maleki L; Nami S
Assay Drug Dev Technol; 2021 Oct; 19(7):453-462. PubMed ID: 34435891
[No Abstract] [Full Text] [Related]
9. A New Amino Acid Substitution at G150S in Lanosterol 14-α Demethylase (Erg11 protein) in Multi-azole-resistant Trichosporon asahii.
Kushima H; Tokimatsu I; Ishii H; Kawano R; Watanabe K; Kadota JI
Med Mycol J; 2017; 58(1):E23-E28. PubMed ID: 28250360
[TBL] [Abstract][Full Text] [Related]
10. Exploring the resistance mechanisms in Trichosporon asahii: Triazoles as the last defense for invasive trichosporonosis.
Padovan ACB; Rocha WPDS; Toti ACM; Freitas de Jesus DF; Chaves GM; Colombo AL
Fungal Genet Biol; 2019 Dec; 133():103267. PubMed ID: 31513917
[TBL] [Abstract][Full Text] [Related]
11. Biofilm formation and antifungal susceptibility of Trichosporon asahii isolates from Mexican patients.
Montoya AM; Elizondo-Zertuche M; Treviño-Rangel RJ; Becerril-García M; González GM
Rev Iberoam Micol; 2018; 35(1):22-26. PubMed ID: 29287630
[TBL] [Abstract][Full Text] [Related]
12. Delineation of the Direct Contribution of Candida auris
Rybak JM; Sharma C; Doorley LA; Barker KS; Palmer GE; Rogers PD
Microbiol Spectr; 2021 Dec; 9(3):e0158521. PubMed ID: 34878305
[TBL] [Abstract][Full Text] [Related]
13. Genotyping and antifungal drug susceptibility of Trichosporon asahii isolated from Chinese patients.
Xia Z; Yang R; Wang W; Cong L
Mycopathologia; 2012 Mar; 173(2-3):127-33. PubMed ID: 21979867
[TBL] [Abstract][Full Text] [Related]
14. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
Sanglard D; Coste AT
Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
[TBL] [Abstract][Full Text] [Related]
15. Comparison of NCCLS microdilution method and Etest in antifungal susceptibility testing of clinical Trichosporon asahii isolates.
Arikan S; Hasçelik G
Diagn Microbiol Infect Dis; 2002 Jun; 43(2):107-11. PubMed ID: 12088616
[TBL] [Abstract][Full Text] [Related]
16. Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing.
Sun W; Su J; Xu S; Yan D
J Med Microbiol; 2012 Dec; 61(Pt 12):1750-1757. PubMed ID: 22956749
[TBL] [Abstract][Full Text] [Related]
17. MDR1 overexpression combined with ERG11 mutations induce high-level fluconazole resistance in Candida tropicalis clinical isolates.
Jin L; Cao Z; Wang Q; Wang Y; Wang X; Chen H; Wang H
BMC Infect Dis; 2018 Apr; 18(1):162. PubMed ID: 29631565
[TBL] [Abstract][Full Text] [Related]
18. Detection of ERG11 Overexpression in Candida albicans isolates from environmental sources and clinical isolates treated with inhibitory and subinhibitory concentrations of fluconazole.
Morais Vasconcelos Oliveira J; Conceição Oliver J; Latércia Tranches Dias A; Barbosa Padovan AC; Siqueira Caixeta E; Caixeta Franco Ariosa M
Mycoses; 2021 Feb; 64(2):220-227. PubMed ID: 33176021
[TBL] [Abstract][Full Text] [Related]
19. MALDI-TOF MS characterisation, genetic diversity and antifungal susceptibility of Trichosporon species from Iranian clinical samples.
Ahangarkani F; Ilkit M; Vaseghi N; Zahedi N; Zomorodian K; Khodavaisy S; Afsarian MH; Abbasi K; de Groot T; Meis JF; Badali H
Mycoses; 2021 Aug; 64(8):918-925. PubMed ID: 33998718
[TBL] [Abstract][Full Text] [Related]
20. [Molecular mechanisms of fluconazole resistance in clinical isolates of Candida glabrata].
Shen YZ; Lu HZ; Zhang YX
Zhonghua Nei Ke Za Zhi; 2010 Mar; 49(3):245-9. PubMed ID: 20450660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]